Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: An example of function versatility of snake venom proteins

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 142, Issue 3-4 SPEC. ISS., 2006, Pages 371-381

  Stábeli, Rodrigo G ^a   Amui, Saulo F ^b   Sant'Ana, Carolina D ^b   Pires, Matheus G ^a   Nomizo, Auro ^b   Monteiro, Marta C ^c   Romão, Pedro R T ^d   Guerra Sá, Renata ^e   Vieira, Carlos A ^b   Giglio, José R ^b   Fontes, Marcos R M ^f   Soares, Andreimar M ^b  

^a UNIR   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDADE ESTADUAL DO CENTRO OESTE   (Brazil)

^d UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^e FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^f SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Bothrops; cDNA cloning; Chemical modification; Microbial; Myotoxin; Parasiticidal and antitumoral activity; Phospholipase A2; Snake venom

Indexed keywords

2 NITROBENZENESULPHONYLFLUORIDE; 4 BROMOPHENACYL BROMIDE; ACETIC ANHYDRIDE; COMPLEMENTARY DNA; CYANOGEN BROMIDE; EDETIC ACID; FLUORIDE; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPASE A2; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES TUMOR; BREAST ADENOCARCINOMA; CANDIDA ALBICANS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LEISHMANIA; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SNAKE;

ANIMALIA; BOTHROPS; BOTHROPS MOOJENI; CANDIDA ALBICANS; ESCHERICHIA COLI; SCHISTOSOMA MANSONI;

EID: 33644993571     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpc.2005.11.020     Document Type: Article

References (58)

1. 2 in Bothrops snake venoms: effects of chemical modifications on the enzymatic and pharmacological properties of Bothrops toxins from Bothrops jararacussu Biochimie 82 2000 755 763
2. 2 from Bothrops jararacussu snake venom Biochem. Pharmacol. 64 2002 723 732
3. 2 from Bothrops asper snake venom Toxicon 39 2001 879 887
4. 2 homologues are reduced, but not abolished, by a pH-induced dissociation Toxicon 46 2005 291 296
5. 2-a structural review Toxicon 34 1996 827 841
6. 2 homologue from Bothrops moojeni venom Prot. Peptide Letters 4 1997 329 334
7. 2 Annu. Rev. Pharmacol. Toxicol. 39 1999 175 189
8. 2 isolated from Bothrops asper (Terciopelo) venom Biochim. Biophys. Acta 1179 1993 253 259
9. M. Carson Ribbons Methods Enzymol. 277 1997 493 505
10. 2 by sequence analysis and site directed mutagenesis Toxicon 42 2003 869 883
11. 2 from cobra venom with cytotoxic properties not related to esterase activity. Purification, amino acid sequence, and biological properties J. Biol. Chem. 264 1989 13289 13297
12. 2 from snake venom are unrelated FEBS Lett. 248 1989 1 4
13. R.E. Corin, L.J. Viskatis, J.C. Vidal, and M.A. Etcheverry Cytotoxicity of crotoxin on murine erythroleukemia cells in vitro Invest. New Drugs 11 1993 11 15
14. 2, NSC-624244) in patients with advanced cancer Clin. Cancer Res. 8 2002 1033 1041
15. 2s in cell injury and death J. Pharmacol. Exp. Ther. 294 2000 793 799
16. 2, reduces its membrane-destabilizing effect Arch. Biochem. Biophys. 312 1994 336 339
17. 2 Enzymes: Structure, Function and Mechanism 1997 John Wiley and Sons Chichester 321 352
18. J.M. Gutiérrez Understanding snake venoms: 50 years of research in Latin America Rev. Biol. Trop. 50 2002 377 394
19. G.M. Kapler, C.M. Coburn, and S.M. Beverley Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression Mol. Cell. Biol. 10 1990 1084 1094
20. 2 Enzymes: Structure, Function and Mechanism 1997 John Wiley and Sons Chichester 1 28
21. 2 enzymes Toxicon 42 2003 827 840
22. B. Lomonte, J.M. Gutierrez, M.F. Furtado, R. Otero, J.P. Rosso, O. Vargas, E. Carmona, and M.E. Rovira Isolation of basic myotoxins from Bothrops moojeni and Bothrops atrox snake venoms Toxicon 28 1990 1137 1146
23. 2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action Toxicon 42 2003 885 901
24. 2: quaternary structure and inhibition mechanism insights Biochem. Biophys. Res. Commun. 311 2003 713 720
25. A.J. Magro, A.A.S. Takeda, A.M. Soares, and M.R.M. Fontes Crystal structure of BthA-I complexed with p-bromophenacyl bromide: possible implications with the lack of pharmacological activities Acta Crystallogr. D61 2005 1670 1677
26. 2 J. Biol. Chem. 261 1986 4797 4804
27. 2 with lysine in place of aspartate 49 J. Biol. Chem. 259 1984 13839 13843
28. 2 from Bothrops moojeni Acta Crystallogr. F61 2005 882 884
29. 2 complexed with p-bromophenacyl bromide. in preparation.
30. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
31. 2s Toxicon 42 2003 903 913
32. 2 J. Biochem. (Tokyo ) 131 2002 285 292
33. 2 Biol. Pharm. Bull. 27 2004 1158 1164
34. C.L. Ownby Structure, function and biophysical aspects of the myotoxins from snake venoms J. Toxicol., Toxin Rev. 17 1998 213 238
35. 2 proteins Toxicon 37 1999 411 445
36. T.J. Nevalainen, R.J. Quinn, and J.N. Hooper Phospholipase A2 in porifera Comp. Biochem. Physiol. B 137 2004 413 420
37. T.J. Nevalainen, H.J. Peuravuori, R.J. Quinn, L.E. Llewellyn, J.A. Benzie, P.J. Fenner, and K.D. Winkel Phospholipase A2 in cnidaria Comp. Biochem. Physiol. B 139 2004 731 735
38. 2 from Bothrops asper snake venom: synthetic Lys49 myotoxin II (115-129)-peptide identifies its bactericidal region Eur. J. Biochem. 253 1998 452 461
39. 2 from Bothrops jararacussu venom Protein J. 23 2004 273 285
40. 2 from Bothrops neuwiedi pauloensis snake venom Toxicon 44 2004 305 314
41. 2 from Indian cobra (Naja naja naja) venom Toxicon 36 1998 921 932
42. 2 from the venom of Agkistrodon piscivorus piscivorus J. Biol. Chem. 267 1992 22645 22657
43. 2 enzymes: classification and characterization Biochim. Biophys. Acta 1488 2000 1 19
44. 2 from snake venoms: effects on catalytic and pharmacological properties Toxicon 15;42 8 2003 855 868
45. A.M. Soares, V.M. Rodrigues, M.I. Homsi-Brandeburgo, M.H. Toyama, F.R. Lombardi, R.K. Arni, and J.R. Giglio A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: biochemical characterization, crystallization, myotoxic and edematogenic activity Toxicon 36 1998 503 514
46. A.M. Soares, S.H. Andrião-Escarso, Y. Angulo, B. Lomonte, J.M. Gutiérrez, S. Marangoni, M.H. Toyama, R.K. Arni, and J.R. Giglio Structural and functional characterization of a myotoxin I from Bothrops moojeni (caissaca) snake venom Arch. Biochem. Biophys. 373 2000 7 15
47. 2 homologue, from Bothrops neuwiedi pauloensis venom Arch. Biochem. Biophys. 378 2000 201 209
48. 2 subunit of crotoxin from Crotalus durissus terrificus snake venom, on its enzymatic and pharmacological activities Int. J. Biochem. Cell Biol. 33 2001 877 888
49. 2 from Bothrops pirajai snake venom Arch. Biochem. Biophys. 387 2001 188 196
50. 2 myotoxin inhibitor protein from Bothrops moojeni snake plasma Biochem. Biophys. Res. Commun. 302 2003 193 200
51. 2 myotoxins from Bothrops snake venoms: structure-function relationship Curr. Org. Chem. 8 2004 1677 1690
52. 2 in Bothrops moojeni venom: a promising approach to an enhanced antivenom production Int. J. Biochem. Cell Biol. 36 2004 258 270
53. 2 from the venom of Australian king brown snake, on its biological activities Toxicon 28 1990 107 117
54. 2 complexed with p-bromophenacyl bromide and alpha-tocopherol inhibitors at 1.9- and 1.45A resolution Biochim. Biophys. Acta 1699 2004 281 284
55. 2 Biochemistry 13 1974 1446 1454
56. 2 Protein Eng. 11 1998 285 294
57. 2 Toxicon 36 1998 1623 1633
58. 2: crystal structure of myotoxin II from Bothrops moojeni complexed with stearic acid Biochimie 87 2005 161 167